vs
Crescent Energy Co（CRGY）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Crescent Energy Co的季度营收约是Royalty Pharma plc的1.4倍（$865.0M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs -1.0%，领先35.4%），Royalty Pharma plc同比增速更快（4.8% vs -1.2%），过去两年Crescent Energy Co的营收复合增速更高（14.7% vs 4.6%）
新月石油是中东地区成立最早、规模最大的私营上游油气企业，1971年成立，总部位于阿联酋沙迦酋长国，目前在阿联酋和伊拉克库尔德斯坦地区均有业务布局。截至2023年，公司已与伊拉克石油部签署三份为期20年的合同，助力伊拉克油气产业重建。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CRGY vs RPRX — 直观对比
营收规模更大
CRGY
是对方的1.4倍
$622.0M
营收增速更快
RPRX
高出5.9%
-1.2%
净利率更高
RPRX
高出35.4%
-1.0%
两年增速更快
CRGY
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $865.0M | $622.0M |
| 净利润 | $-8.7M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | -6.2% | 62.4% |
| 净利率 | -1.0% | 34.4% |
| 营收同比 | -1.2% | 4.8% |
| 净利润同比 | 92.7% | 2.9% |
| 每股收益（稀释后） | — | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRGYRPRX
| Q4 25 | $865.0M | $622.0M | ||
| Q3 25 | $866.6M | $609.3M | ||
| Q2 25 | $898.0M | $578.7M | ||
| Q1 25 | $950.2M | $568.2M | ||
| Q4 24 | $875.3M | $593.6M | ||
| Q3 24 | $744.9M | $564.7M | ||
| Q2 24 | $653.3M | $537.3M | ||
| Q1 24 | $657.5M | $568.0M |
净利润CRGYRPRX
| Q4 25 | $-8.7M | $214.2M | ||
| Q3 25 | $-9.5M | $288.2M | ||
| Q2 25 | $153.2M | $30.2M | ||
| Q1 25 | $-2.1M | $238.3M | ||
| Q4 24 | $-118.0M | $208.2M | ||
| Q3 24 | $-9.9M | $544.0M | ||
| Q2 24 | $37.5M | $102.0M | ||
| Q1 24 | $-24.2M | $4.8M |
营业利润率CRGYRPRX
| Q4 25 | -6.2% | 62.4% | ||
| Q3 25 | 3.6% | 70.1% | ||
| Q2 25 | 8.9% | 36.3% | ||
| Q1 25 | 18.1% | 94.0% | ||
| Q4 24 | -3.1% | 60.9% | ||
| Q3 24 | -1.0% | — | ||
| Q2 24 | 18.3% | 50.2% | ||
| Q1 24 | 20.4% | -13.0% |
净利率CRGYRPRX
| Q4 25 | -1.0% | 34.4% | ||
| Q3 25 | -1.1% | 47.3% | ||
| Q2 25 | 17.1% | 5.2% | ||
| Q1 25 | -0.2% | 41.9% | ||
| Q4 24 | -13.5% | 35.1% | ||
| Q3 24 | -1.3% | 96.3% | ||
| Q2 24 | 5.7% | 19.0% | ||
| Q1 24 | -3.7% | 0.8% |
每股收益（稀释后）CRGYRPRX
| Q4 25 | — | $0.49 | ||
| Q3 25 | — | $0.67 | ||
| Q2 25 | — | $0.07 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | $0.46 | ||
| Q3 24 | — | $1.21 | ||
| Q2 24 | — | $0.23 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.2M | $618.7M |
| 总债务越低越好 | $5.5B | $9.0B |
| 股东权益账面价值 | $5.2B | $9.7B |
| 总资产 | $12.4B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.07× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CRGYRPRX
| Q4 25 | $10.2M | $618.7M | ||
| Q3 25 | $3.5M | $938.9M | ||
| Q2 25 | $3.1M | $631.9M | ||
| Q1 25 | $6.3M | $1.1B | ||
| Q4 24 | $132.8M | $929.0M | ||
| Q3 24 | $136.2M | $950.1M | ||
| Q2 24 | $778.1M | $1.8B | ||
| Q1 24 | $5.3M | $843.0M |
总债务CRGYRPRX
| Q4 25 | $5.5B | $9.0B | ||
| Q3 25 | $3.2B | $8.9B | ||
| Q2 25 | $3.4B | $8.0B | ||
| Q1 25 | $3.6B | $7.6B | ||
| Q4 24 | $3.0B | $7.6B | ||
| Q3 24 | $3.2B | $7.6B | ||
| Q2 24 | $2.4B | $7.6B | ||
| Q1 24 | $1.7B | $6.1B |
股东权益CRGYRPRX
| Q4 25 | $5.2B | $9.7B | ||
| Q3 25 | $4.5B | $9.6B | ||
| Q2 25 | $4.5B | $9.5B | ||
| Q1 25 | $3.3B | $9.8B | ||
| Q4 24 | $3.1B | $10.3B | ||
| Q3 24 | $2.9B | $10.3B | ||
| Q2 24 | $2.1B | $9.8B | ||
| Q1 24 | $2.0B | $9.9B |
总资产CRGYRPRX
| Q4 25 | $12.4B | $19.6B | ||
| Q3 25 | $9.7B | $19.3B | ||
| Q2 25 | $9.9B | $18.3B | ||
| Q1 25 | $9.9B | $17.6B | ||
| Q4 24 | $9.2B | $18.2B | ||
| Q3 24 | $9.3B | $18.0B | ||
| Q2 24 | $7.5B | $17.7B | ||
| Q1 24 | $6.8B | $16.1B |
负债/权益比CRGYRPRX
| Q4 25 | 1.07× | 0.92× | ||
| Q3 25 | 0.72× | 0.93× | ||
| Q2 25 | 0.75× | 0.84× | ||
| Q1 25 | 1.10× | 0.78× | ||
| Q4 24 | 0.97× | 0.74× | ||
| Q3 24 | 1.12× | 0.74× | ||
| Q2 24 | 1.12× | 0.78× | ||
| Q1 24 | 0.88× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $371.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CRGYRPRX
| Q4 25 | $371.0M | $827.1M | ||
| Q3 25 | $473.1M | $702.6M | ||
| Q2 25 | $499.0M | $364.0M | ||
| Q1 25 | $337.1M | $596.1M | ||
| Q4 24 | $384.4M | $742.5M | ||
| Q3 24 | $368.0M | $703.6M | ||
| Q2 24 | $286.9M | $658.2M | ||
| Q1 24 | $183.8M | $664.6M |
现金转化率CRGYRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | 3.26× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 7.64× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRGY
| Oil Reserves | $554.3M | 64% |
| Natural Gas Production | $182.6M | 21% |
| Natural Gas Liquids Reserves | $92.3M | 11% |
| Midstream And Other | $35.8M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
